Despite the White House’s promise of aggressive action to end skyrocketing drug prices and the enactment of a new state law that is supposed to cap the state’s prescription spending under Medicaid and Medicare, local consumers and patients likely won’t see relief at the pharmacy counter any time soon.
Ohio Medicaid Audit Only Proves that Transparency is Critical to Reforming a Broken System that Benefits Shareholders Before Patients
The release last week of the HealthPlan Data Solutions report allegedly “vindicating” CVS Caremark and other large pharmacy benefit managers accused of overbilling Ohio Medicaid and reimbursing Ohio pharmacies at or below the cost for Medicaid prescriptions only proves what everyone already knows: numbers can be arranged favorable to just about any outcome.
More than eyebrows should be raised at the news that Illinois Health and Family Services (HFS) Director Felicia Norwood has resigned to take a position with Anthem, a for-profit subsidiary of health insurer Blue Cross Blue Shield. The resignation of Ms. Norwood, a government “insider” who will head up the company’s division tasked with landing government contracts, should raise questions about the propriety of the move, and if it violates Illinois’ Revolving Door Act